Please login to the form below
arthritis
This page shows the latest arthritis news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
Novartis agrees to help produce Roche’s repurposed COVID-19 drug
Actemra/RoActemra (tocilizumab) is already approved to treat a number of inflammatory conditions, including rheumatoid arthritis, paediatric juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, giant cell arteritis and CAR-T
-
Researchers use AI to identify drugs that could be repurposed for Alzheimer’s
JAK inhibitors are commonly used to treat conditions such as rheumatoid arthritis and blood cancers, and block the action of JAK proteins, which play a role in inflammation and are also
-
Roche’s anti-inflammatory drug reduces deaths in hospitalised COVID-19 patients
Tocilizumab, which is commonly used to treat rheumatoid arthritis, was found to reduce the relative risk of death by 14% when used alongside the steroid dexamethasone in COVID-19 patients requiring
-
FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz
Xeljanz is approved in the US for use in adults with rheumatoid arthritis (RA) who have not responded well to methotrexate treatment. ... It is also approved to treat patients with psoriatic arthritis who have not responded well to prior methotrexate
-
Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
JAK inhibitor approved for use in moderate-to-severe RA. Gilead Sciences’ rheumatoid arthritis (RA) treatment Jyseleca has been given a recommendation from the UK’s National Institute of Health and
More from news
Approximately 97 fully matching, plus 657 partially matching documents found.
Latest Intelligence
-
Setting up for success in a post-Brexit, post-pandemic Britain
and Rheumatoid Arthritis (RA). ... people with moderate as well as severe rheumatoid arthritis – aiming to avoid irreversible damage as early as possible.
-
Helping patients to help themselves – how pharma can get more from patient support programmes
For example, when developing a patient support programme for patients with Ankylosing Spondylitis and Psoriatic Arthritis, earthware identified that, for newly diagnosed patients, the impact of receiving the diagnosis on their
-
The US celebrates five years of biosimilars on the market – a look to the past, present and future
chronic diseases such as rheumatoid arthritis.
-
Innovation in a digital context is not about technology – it’s about people
We have also been continuously developing new content based on patients’ needs: an interactive treatment pathway, an interactive appointment-preparation video, ever-growing support for psoriatic arthritis, advice on treatments and
-
NICE – but not enough
to severe rheumatoid arthritis.
More from intelligence
Approximately 0 fully matching, plus 58 partially matching documents found.
Latest appointments
-
Aurora boosts team with new hires and internal promotions
Prior to joining Aurora in 2015, O’Farrell worked at the patient group Arthritis Ireland.
-
Portland Health appoints Jamie Hewitt as an account director
He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions. ... During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to
-
Liberation Unlimited promotes Vicky Smith
oncology, rheumatoid arthritis and eye health.
-
Galapagos appoints Bart Filius as chief financial officer
His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
-
TiGenix appoints Dr Marie Paule Richard
In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
What you can do to help make invisible illnesses more visible?
This can include chronic physical conditions like arthritis and diabetes, or mental illnesses.
-
Covid-19: how is it affecting prescribing patterns?
Rheumatoid arthritis. Rheumatoid arthritis has seen a significant rise in prescribing rates for biosimilars. ... because as generic biologics get approved, use of branded biologics goes down and the arthritis pathway becomes cheaper to run.
-
The other side of … rheumatoid arthritis
The other side of … rheumatoid arthritis. “I harassed my GP enough to get it caught early”. ... Meet Georgie. At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population
-
Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards
arthritis (RA): Is there a missing link in RA management?
-
Lucid Group scoop a win and a high commendation at Communiqué 2020
Its programme – ‘LiBRA 2019: Looking beyond the joint in rheumatoid arthritis (RA): Is there a missing link in RA management?’ – won the category, with a high commendation going to ‘CLEAR HORIZONS – ... We were thrilled that our work in both
More from PMHub
Approximately 10 fully matching, plus 31 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Senior Medical Writer
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
-
Medical Editor
-
Competitive Salary
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Associate Account Director
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
-
Publications Director
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Merck & Co reveals plans for women’s health spinoff Organon
- bluebird bio aiming to separate business units by year-end
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Lilly signs $1.25bn collaboration deal with MiNA Therapeutics
- Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021
- Emergency authorisation for Pfizer/BioNTech vaccine expanded in the US
- Biogen and Capsigen to collaborate on gene therapies
- AZ, Amgen file first-in-class asthma drug with the FDA
- Sharing patient stories for World Pulmonary Hypertension Day
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- AZ, Amgen file first-in-class asthma drug with the FDA
- US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
- The new reality of building a corporate brand in pharma
- FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
PMHub
Fishawack Health
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...
Latest intelligence
- Sharing patient stories for World Pulmonary Hypertension Day
- For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
- How nature can help you manage the pressures of agency life
- Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
